Articles From: - The Medicines Company to Host Infectious Disease Care Investor and Analyst Meeting on September 24, 2014 to - Kaman Reports 2014 Second Quarter Results


The Medicines Company (NASDAQ:MDCO) has scheduled an Infectious Disease Care Investor and Analyst meeting for Wednesday, September 24, 2014 from 8:30 am to 12:00 noon.
Sign-up for - The Medicines Company to Host Infectious Disease Care Investor and Analyst Meeting on September 24, 2014 investment picks
URS Corporation (NYSE:URS) will announce its 2014 second quarter results after the market closes on Tuesday, August 12, 2014.
Sign-up for - URS Corporation to Release 2014 Second Quarter Results on August 12, 2014 investment picks
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, has initiated a Phase 2a study to evaluate the safety and tolerability of NPSP795 in adult patients with Autosomal Dominant Hypocalcemia (ADH), an ultra-rare genetic disorder of calcium homeostasis.
Sign-up for - NPS Pharma Initiates Phase 2a Study of NPSP795 in Adult Patients with Autosomal Dominant Hypocalcemia (ADH) investment picks
2014/8/4
CHARLOTTE, N.C. , Aug.
Sign-up for 2014/8/4 - UTC Aerospace Systems selected by Boeing to design and build nacelle systems for the Boeing 787-10 Dreamliner investment picks
HR4x00 Branch Gateway honored for branch networking security and performance innovations GERMANTOWN, Md.
Sign-up for - Hughes Receives a 2014 Communications Solutions Product of the Year Award by TMC investment picks
2014/8/4
New Assessment and Deployment Services Enable Channel Partners to More Effectively Sell and Support EMC VNX and Unified Communications and Collaboration Solutions SANTA ANA, Calif.
Sign-up for 2014/8/4 - Ingram Micro's New Expert Services Expand Channel Partners' Capabilties to Sell and Deploy Advanced Solutions investment picks
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- HSBC PLC shares rose Monday following the banking heavyweight's financial results, helping to lift the benchmark FTSE 100 index.
Sign-up for - UPDATE: HSBC shares lead climb in U.K. stocks investment picks
BURLINGTON, Mass., Aug.
Sign-up for - Aldeyra Therapeutics Reports Second Quarter 2014 Financial Results investment picks
2014/8/4
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135186&ProfileId=051205&sourceType=1 DENVER, CO --
Sign-up for 2014/8/4 - Latteno's Rx Harvest Collective Acquires S. Orange County MMJ Delivery Service investment picks
2014/8/4
-- Non-GAAP1 diluted earnings per share from continuing operations increased 5 percent to $0.83 per share for the fourth quarter and 3 percent to $3.84 per share for fiscal 2014 --
Sign-up for 2014/8/4 - Cardinal Health Reports Fourth-Quarter And Fiscal Year Results, Provides Fiscal 2015 Outlook investment picks
- Over 1700 Participants Focused on Superconductivity Industry and Technology - AUSTIN, Texas, Aug.
Sign-up for - Superconductor Technologies Inc. to Present and Exhibit at the Applied Superconductivity Conference August 10th to 14th investment picks
2014/8/4
SHENZHEN, China , Aug.
Sign-up for 2014/8/4 - Nam Tai Property Inc. Reports Q2 2014 Results investment picks
2014/8/4
By Patricia Kowsmann Lender's toxic assets would become part of bad bank -Patricia Kowsmann; 415-439-6400; AskNewswires@dowjones.com LISBON -- Portugal's central bank late Sunday unveiled a plan to rescue the country's second-largest lender by breaking up the bank and pumping in billions of euros of state money.
Sign-up for 2014/8/4 - UPDATE: Bank of Portugal unveils Banco Espírito Santo rescue plan investment picks
Allied Minds (LSE: ALM) and Bristol-Myers Squibb Company (NYSE: BMY) today announced the formation of Allied-Bristol Life Sciences LLC, a new jointly owned enterprise created to identify and foster research and pre-clinical development of biopharmaceutical innovations from leading university research institutions across the U.S. Allied-Bristol Life Sciences LLC will focus on efficiently and effectively converting discoveries from university research institutions into therapeutic candidates for clinical development, and ultimately approved therapies that address serious diseases.
Sign-up for - Allied Minds and Bristol-Myers Squibb Form New Enterprise to Advance Discoveries of Biopharmaceutical Innovations at Leading U.S. Academic Research Institutions investment picks
Highlights: - Provides best-in-class transistor-level EMIR accuracy, enabled by Spectre Accelerated Parallel Simulator SPICE simulation - Voltus-Fi Custom Power Integrity Solution completes Cadence power signoff solution - Delivers best-in-class accuracy for advanced node FinFET process SAN JOSE, Calif.
Sign-up for - Cadence Introduces Voltus-Fi Custom Power Integrity Solution, Delivering Foundry-Certified SPICE-Level Accuracy for Transistor-Level Power Signoff investment picks
Kayne Anderson Midstream/Energy Fund, Inc. (the “Fund”) (NYSE:KMF) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of July 31, 2014.
Sign-up for - Kayne Anderson Midstream/Energy Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios at July 31, 2014 investment picks
Justice Department and multi-state AG settlement resolves alleged scheme of over-admitting patients at nearly 120 CHS hospitals across 20 states; whistleblowers include former ER physician in Philadelphia WASHINGTON , Aug.
Sign-up for - Grant & Eisenhofer Represents Whistleblowers in Nearly $100 Million Settlement With Community Health Systems, Resolving Claims that Medicare/Medicaid Payors Were Bilked by Excessive ER Admissions investment picks
2014/8/4
By Quentin Fottrell, MarketWatch Far more expensive than tap water--and often, no healthier -Quentin Fottrell; 415-439-6400; AskNewswires@dowjones.com It's far more expensive than tap water--and often, no healthier -Quentin Fottrell; 415-439-6400; AskNewswires@dowjones.com The crisis over unsafe tap water in Toledo, Ohio impacted roughly half a million people in recent days.
Sign-up for 2014/8/4 - UPDATE: Why you should stop buying bottled water investment picks
2014/8/4
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135320&ProfileId=051205&sourceType=1 HENDERSON, NV --
Sign-up for 2014/8/4 - Force Fuels, Inc. Subsidiary Cafe Serendipity Inc., Signs Its First Franchise Agreement for a Branded Recreational Marijuana Store in Colorado. investment picks
Albany International Corp.
Sign-up for - Albany International Reports Second-Quarter Results investment picks
MILWAUKEE , Aug.
Sign-up for - Bank Mutual Corporation Announces Quarterly Cash Dividend investment picks
Berry Plastics Group, Inc. (NYSE: BERY) (the “Company”) announced today the commencement of a secondary public offering of 14,728,218 shares of the Company’s common stock by certain funds affiliated with Apollo Global Management, LLC (collectively, the “Selling Stockholders”). The Company itself is not selling any shares and will not receive any proceeds from the proposed offering, and it will not change the number of shares of the Company’s common stock that are currently outstanding.
Sign-up for - Berry Plastics Group, Inc. Announces Secondary Public Offering investment picks
Q3 non-GAAP revenue and non-GAAP EPS exceed guidance Company reports Q3 non-GAAP revenue growth of 28% BELLEVUE, Wash.
Sign-up for - Concur Reports Results for Fiscal 2014 Third Quarter investment picks
By Claudia Assis and Al Lewis, MarketWatch Utility-scale solar deals are seen more competitive, less profitable -Claudia Assis; 415-439-6400; AskNewswires@dowjones.com SAN FRANCISCO (MarketWatch) -- First Solar Inc. will report second-quarter results after the market closes on Tuesday, and Wall Street will be keen to see whether the solar developer can regain momentum.
Sign-up for - First Solar looks to regain momentum after earnings investment picks
Kaman Corp.
Sign-up for - Kaman Reports 2014 Second Quarter Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: - The Medicines Company to Host Infectious Disease Care Investor and Analyst Meeting on September 24, 2014 to - Kaman Reports 2014 Second Quarter Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices